BioSyent Inc. (TSXV:RX)
Canada flag Canada · Delayed Price · Currency is CAD
14.63
+0.22 (1.53%)
Apr 8, 2026, 12:15 PM EST

BioSyent Balance Sheet

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
21.7912.117.987.8618.04
Short-Term Investments
6.863.8318.220.8310.18
Cash & Short-Term Investments
28.6515.9426.1928.728.21
Cash Growth
79.74%-39.13%-8.74%1.72%10.30%
Accounts Receivable
4.462.913.483.52.79
Other Receivables
0.080.090.070.160.42
Total Trade Receivables
4.542.993.553.663.21
Inventory
6.425.335.894.542.2
Other Current Assets
0.190.210.240.250.46
Total Current Assets
39.7924.4735.8737.1434.08
Net Property, Plant & Equipment
0.981.21.441.671.93
Other Intangible Assets
4.85.041.151.20.87
Long-Term Investments
3.3610.242.710.260.18
Other Long-Term Assets
0.510.40.360.210.1
Total Assets
49.4441.3641.5340.4937.17
Accounts Payable
6.1545.085.063.56
Current Portion of Leases
0.210.20.180.170.16
Unearned Revenue
0.420.810.130.160.31
Other Current Liabilities
0.430.40.140.320.1
Total Current Liabilities
7.225.415.535.724.14
Long-Term Leases
0.630.841.041.221.4
Other Long-Term Liabilities
0.130.110.20.180.08
Total Long-Term Liabilities
0.760.951.241.41.48
Total Liabilities
7.976.366.777.125.61
Common Stock
5.255.315.125.375.8
Additional Paid-in Capital
2.162.142.292.231.82
Accumulated Other Comprehensive Income
-0.18-0.17-0.18-0.14-0.19
Retained Earnings
34.2427.7327.5325.9124.12
Shareholders' Equity
41.473534.7633.3631.55
Total Liabilities & Equity
49.4441.3641.5340.4937.17
Total Debt
0.841.041.221.41.56
Net Cash (Debt)
27.8114.924.9727.326.65
Net Cash Growth
86.61%-40.31%-8.55%2.42%11.67%
Net Cash Per Share
2.421.262.052.182.07
Book Value
41.473534.7633.3631.55
Book Value Per Share
3.602.962.862.662.45
Tangible Book Value
36.6729.9633.6132.1630.68
Tangible Book Value Per Share
3.192.542.762.562.38
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.